ACLS Provider: Course

Incorrect. Waveform capnography ensures proper ET tube placement by continuously monitoring exhaled CO? levels.

Incorrect. Ventilations are delivered at a rate of 6-8 breaths per minute to prevent hyperventilation.

Incorrect. Delivers an electrical shock to depolarize the heart and restore a normal rhythm.

Incorrect. Hypothermia is a reversible cause of cardiac arrest and is treated by warming the patient to improve outcomes.

Incorrect. Epinephrine is given first in VF during cardiac arrest, followed by amiodarone as an antiarrhythmic after defibrillation attempts.

Incorrect. Synchronized cardioversion with 50-100 J is effective for narrow, regular tachycardias that are unstable.

Incorrect. Epinephrine at 0.01 mg/kg is administered every 3-5 minutes during pediatric cardiac arrest to improve coronary perfusion.

Incorrect. Calling for help ensures timely assistance and access to advanced resuscitation equipment.

Incorrect. Synchronized cardioversion is indicated for unstable atrial fibrillation to restore sinus rhythm and prevent hemodynamic collapse.

Incorrect. IM epinephrine is the first-line treatment for anaphylaxis, administered into the mid-thigh for rapid absorption.

Incorrect. Epinephrine is dosed at 0.01 mg/kg IV/IO during pediatric cardiac arrest to improve coronary and cerebral perfusion.

Incorrect. Requires immediate defibrillation to restore organized cardiac activity.

Incorrect. The correct initial dose of amiodarone for pulseless VT is 300 mg IV/IO, followed by 150 mg for a second dose if needed.

Incorrect. A rate of 100-120 compressions per minute optimizes perfusion without compromising cardiac filling.

Incorrect. Magnesium sulfate stabilizes the cardiac membrane and is the drug of choice for treating torsades de pointes.

Incorrect. Delivering 6-8 breaths per minute minimizes interruptions in chest compressions and prevents hyperventilation.

Incorrect. PETCO2 monitoring provides real-time feedback on chest compressions and the effectiveness of CPR.

Incorrect. PETCO2 monitoring ensures effective ventilation and provides feedback on the quality of chest compressions during CPR.

Incorrect. Naloxone is only used in cases of suspected opioid overdose and is not universally administered in cardiac arrest.

Incorrect. Hypothermia is a reversible cause of cardiac arrest and should be treated with warming measures.

Incorrect. The correct compression-to-ventilation ratio for adult CPR without an advanced airway is 30:2.

Incorrect. The 15:2 ratio improves oxygenation and circulation during high-quality infant CPR performed by two rescuers.

Incorrect. PETCO2 readings above 10 mmHg during CPR indicate adequate chest compressions and cardiac output.

Incorrect. Asystole is a non-shockable rhythm requiring immediate high-quality CPR and administration of epinephrine.

Incorrect. A PETCO2 reading above 10 mmHg indicates adequate chest compressions and cardiac output during CPR.

Incorrect. Ventricular fibrillation (VF) is a shockable rhythm and requires immediate defibrillation to restore an organized rhythm.

Incorrect. Naloxone reverses opioid-induced respiratory depression, restoring normal respiratory function.

Incorrect. The jaw thrust maneuver opens the airway without moving the cervical spine, reducing the risk of spinal injury.

Incorrect. Pediatric defibrillation begins at 2 J/kg for the first shock and increases as necessary for subsequent shocks.

Incorrect. Naloxone is used to reverse opioid overdose, restoring respiratory effort in patients with respiratory depression.

Incorrect. The maximum dose of atropine for bradycardia is 3 mg, with doses given at 0.5 mg intervals every 3-5 minutes.

Incorrect. Asystole is not a shockable rhythm; it is treated with high-quality CPR and epinephrine.

Incorrect. Prevents progression to cardiac arrest by restoring a normal rhythm.

Incorrect. A 15:2 ratio ensures optimal oxygenation and circulation during two-rescuer CPR in pediatric patients.

Incorrect. High-quality CPR is the primary intervention for PEA, followed by epinephrine administration and addressing reversible causes.

Incorrect. PEA is not treated with adenosine; it is managed with CPR, epinephrine, and identifying and treating reversible causes.

Incorrect. PEA is treated with CPR and epinephrine, as defibrillation is ineffective for non-shockable rhythms.

Incorrect. Magnesium sulfate stabilizes the myocardium and is the first-line treatment for torsades de pointes.

Incorrect. Needle decompression relieves pressure caused by tension pneumothorax, improving ventilation and circulation.

Incorrect. Amiodarone is preferred, but lidocaine is an alternative antiarrhythmic for refractory VF or pulseless VT.

Incorrect. Immediate CPR is required as asystole is a non-shockable rhythm.

Incorrect. Oxygenation and ventilation should be optimized to avoid hypoxia or hyperoxia during post-cardiac arrest care.

Incorrect. A PETCO2 reading above 10 mmHg indicates that chest compressions are generating sufficient circulation during CPR.

Incorrect. Hypovolemia is a reversible cause of cardiac arrest and should be corrected with fluid resuscitation.

Incorrect. With an advanced airway in place, compressions continue uninterrupted while breaths are delivered at 6-8 breaths per minute.

Incorrect. Oxygenation and ventilation should be closely monitored to prevent hypoxia and hyperoxia.

Incorrect. PEA is not a shockable rhythm; it is managed with high-quality CPR and addressing the underlying reversible causes.

Incorrect. Adenosine is the first-line drug for treating narrow-complex SVT by slowing conduction through the AV node.

Incorrect. Compressing to a depth of 2-2.4 inches ensures adequate circulation without causing damage to internal organs.

Incorrect. Hypoxia is a reversible cause of PEA; it must be treated immediately with oxygenation and ventilation.

Incorrect. Post-ROSC care focuses on optimizing oxygenation, ventilation, and hemodynamic stability to prevent further organ damage.

Incorrect. If VF persists after defibrillation and epinephrine, amiodarone is administered to stabilize the rhythm.

Incorrect. Symptomatic second-degree AV block type II can progress to complete heart block, requiring pacing.

Incorrect. Interruptions in chest compressions should not exceed 10 seconds to maintain adequate perfusion to vital organs.

Incorrect. Epinephrine is the first-line drug for VF, with amiodarone as the preferred antiarrhythmic for refractory cases.

Incorrect. Early defibrillation is critical for survival, especially in shockable rhythms like VF/VT.

Incorrect. Magnesium sulfate stabilizes the myocardium and is the drug of choice for torsades de pointes.

Incorrect. Synchronized cardioversion is the treatment of choice for unstable ventricular tachycardia with a pulse.

Incorrect. These shockable rhythms require immediate defibrillation to restore a perfusing rhythm.

Incorrect. VF is a shockable rhythm requiring immediate defibrillation to restore organized cardiac activity.

Incorrect. VF is a shockable rhythm requiring immediate defibrillation to restore an organized cardiac rhythm.

Incorrect. A rate of 100-120 compressions per minute ensures adequate circulation in pediatric patients.

Incorrect. The same compression rate as adults ensures adequate perfusion in pediatric patients during CPR.

Incorrect. PEA is not a shockable rhythm; it is treated with CPR and addressing reversible causes such as hypoxia or hypovolemia.

Incorrect. Ventilations should be provided at a controlled rate of 6-8 breaths per minute to prevent hyperventilation.